As the newly formed vessels are mostly immature and their genesis is mediated by vascular endothelial growth factor (VEGF), patients with tumors developed on the background of cirrhosis might respond to anti‐VEGF medications. This evidence concerns the gene VEGFA and Cirrhosis.